[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368885-105":59,"doc-detail-368885-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","histopathology-based-assessment-of-the-tumour-microenvironment-in-gastrointestinal-cancers-practical-approaches-to-prognostication-and-treatment-stratification","Histopathology-based assessment of the tumour microenvironment in gastrointestinal cancers - practical approaches to prognostication and treatment stratiﬁcation","","The tumour microenvironment (TME) drives carcinogenesis by shaping tumour growth, invasion, metastasis, and drug resistance, making reliable evaluation crucial for gastrointestinal cancers. Histopathology and immunohistochemistry offer accessible, reproducible ways to quantify TME features, including immune checkpoint and immune cell marker expression, and support prognostic and predictive risk stratification. Four Journal of Pathology Clinical Research papers are reviewed, highlighting practical scoring tools for colorectal, gastric, and gastroenteropancreatic neuroendocrine neoplasms, with emphasis on cost-effective multicentre validation and integration with digital pathology and molecular data.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/histopathology-based-assessment-of-the-tumour-microenvironment-in-gastrointestinal-cancers-practical-approaches-to-prognostication-and-treatment-stratification/368885/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/histopathology-based-assessment-of-the-tumour-microenvironment-in-gastrointestinal-cancers-practical-approaches-to-prognostication-and-treatment-stratification/368885.png","ImageObject",300,407,{"name":92,"@type":93},"Mary Man","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":14},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is the tumour microenvironment (TME) important in gastrointestinal cancers?","Question",{"text":112,"@type":113},"The TME influences carcinogenesis by affecting tumour growth, invasion, metastasis, and drug resistance. Evaluating these interactions supports prognostic and predictive decision-making.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What methodologies are emphasized for TME assessment?",{"text":117,"@type":113},"Histopathology and immunohistochemistry are highlighted as accessible and reproducible approaches for evaluating TME in gastrointestinal cancers.",{"name":119,"@type":110,"acceptedAnswer":120},"Which scoring or panel approaches are described as being developed in the reviewed papers?",{"text":121,"@type":113},"The commentary discusses the Tumour Microenvironment Score (TMS), Combined Immune Checkpoint Stromal Score (CICSS), Immune Score for Gastric Cancer (ISGC), and a multicomponent microenvironment and tumour inflammatory features panel (MoTIFs).","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368885,1790179071,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":14,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":19,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":129,"read_time":52,"preview_page_count":19,"preview_urls":143},7421720224475,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","The Journal of Pathology: Clinical Research J Pathol Clin Res November 2025; 11: e70053 Published online in Wiley Online Library (wi[leyonlinelibrary.com](leyonlinelibrary.com). DOI: 10.1002/2056-4538.70053)[).](leyonlinelibrary.com). DOI: 10.1002/2056-4538.70053)[ DOI: 10.1002/2056-4538.70053](leyonlinelibrary.com). DOI: 10.1002/2056-4538.70053)  \nINVITED COMMENTARY  \nHistopathology-based assessment of the tumour microenvironment in gastrointestinal cancers: practical approaches to prognostication and treatment stratiﬁ cation  \nShelly Yunbi Ni, Howard Ho-Wai Leung and Anthony Wing-Hung Chan*   \nDepartment of Anatomical and Cellular Pathology, State Key Laboratory in Oncology in South China, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong  \n*Correspondence to: Anthony Wing-Hung Chan, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Ngan Shing Street, Shatin, NT, Hong Kong. E-mail: [awh_chan@cuhk.edu.hk](awh_chan@cuhk.edu.hk)  \nAbstract  \nThe tumour microenvironment (TME) is a key factor in carcinogenesis by affecting tumour growth, invasion, metastasis, and drug resistance. Histopathology and immunohistochemistry provide accessible and reproducible methodologies for TME evaluation, with growing evidence supporting their prognostic and predictive signiﬁcancein gastrointestinal cancers. This commentary examines four papers published in the Journal of Pathology:  \nClinical Research that illustrate this methodology across various gastrointestinal cancers. The Tumour Microenvironment Score, Combined Immune Checkpoint Stromal Score, Immune Score for Gastric Cancer, and the multicomponent microenvironment and tumour inﬂammatory features panel have been developed to assess TME characteristics in colorectal cancer, gastric cancer, and gastroenteropancreatic neuroendocrine neoplasm.  \nThe reviewed studies demonstrate that basic morphological characteristics together with the expression of immune checkpoint markers and immune cell markers enable the development of effective clinical tools to enhance risk assessment and treatment planning. These practical, cost-effective, and promising methods need to undergo extensive multicentre testing with established protocols, digital pathology, and molecular information integration.  \nKeywords: tumour microenvironment; histopathology; immunohistochemistry; gastrointestinal cancer; colorectal cancer; gastric cancer; gastroenteropancreatic neuroendocrine neoplasm; prognosis  \nReceived 16 September 2025; Revised 19 September 2025; Accepted 24 September 2025 No conﬂicts of interest were declared.  \nThe tumour microenvironment (TME) is a key factor in carcinogenesis by affecting tumour growth, invasion, metastasis, and drug resistance. Understanding the complex and dynamic interactions between tumour cells and their microenvironment, encompassing immune cells, stromal components, and inﬂammatory mediators, will help ﬁnd biomarkers for predicting patient outcomes and formulating treatment strategies. The challenge of bringing TME research to clinical practice is developing a scientiﬁcally valid and simple evaluation method. While sophisticated molecular techniques offer detailed insights into the immune landscape, they have signiﬁcant challenges, including high costs, lengthy processing times, and the need for specialised expertise. In contrast, assessing TME by conventional histology and immunohistochemistry  \nmethods may provide comparable prognostic and predictive capabilities. Gastrointestinal malignancies constitute a substantial global health challenge, accounting for 26% of cancer incidence and 35% of cancer-related deaths worldwide [1] . It is worth investigating whether TME evaluation using histology and immunohistochemistry is beneﬁcial in gastrointestinal malignancies. Four papers published in the Journal of Pathology: Clinical Research demonstrate this approach for various gastrointestinal cancers ","cbCaidBGyrvFChY1","https://ap.wps.com/l/cbCaidBGyrvFChY1","pdf",3161765,"English","# Invited Commentary\n## Abstract\n## Keywords\n## Background and Rationale\n## Overview of Reviewed Studies","[{\"question\":\"Why is the tumour microenvironment (TME) important in gastrointestinal cancers?\",\"answer\":\"The TME influences carcinogenesis by affecting tumour growth, invasion, metastasis, and drug resistance. Evaluating these interactions supports prognostic and predictive decision-making.\"},{\"question\":\"What methodologies are emphasized for TME assessment?\",\"answer\":\"Histopathology and immunohistochemistry are highlighted as accessible and reproducible approaches for evaluating TME in gastrointestinal cancers.\"},{\"question\":\"Which scoring or panel approaches are described as being developed in the reviewed papers?\",\"answer\":\"The commentary discusses the Tumour Microenvironment Score (TMS), Combined Immune Checkpoint Stromal Score (CICSS), Immune Score for Gastric Cancer (ISGC), and a multicomponent microenvironment and tumour inflammatory features panel (MoTIFs).\"}]","Histopathology-based assessment of the tumour microenvironment in gastrointestinal cancers - practical approaches to prognostication and treatment stratiﬁcation | PDF",[144,148,152,156],{"page_no":8,"url":145,"width":146,"height":147},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b3ff3371aae2e3d59e0c7f54856ae63.webp",983,1291,{"page_no":14,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8d2ca7e9c42df71ad922287b3107fd9.webp",982,1290,{"page_no":81,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/135e93a0ec38d801f4b79eedade788a1.webp",981,1289,{"page_no":19,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/802da98af0ccabd61c2de4bf556e8b1a.webp",980,1287]